Medikamentöse Therapieansätze bei Sterilität

Literatur

• 1 Evers J L. Female subfertility.  Lancet. 2002;  360 151-159
• 2 Jahresbericht des Deutschen IVF Registers 2001: http://www.deutsches-ivf-register.de/jahresbericht.htm . 2003
• 3 Krassas G E. Thyroid disease and female reproduction.  Fertil Steril. 2002;  74 1063-1070
• 4 Raber W, Nowotny P, Vytiska-Binstorfer E, Vierhapper H. Thyroxine treatment modified in infertile women according to thyroxine-releasing hormone testing: 5 year follow-up of 283 women referred after exclusion of absolute causes of infertility.  Hum Reprod. 2003;  18 707-714
• 5 Hughes E, Collins J, Vandekerckhove P. Bromocriptine for unexplained subfertility in women. Cochrane Database Syst 2003 RevCD000044. 
• 6 Tartagni M, Nicastri P L, Diaferia A, Di G I, Loizzi P. Long-term follow-up of women with amenorrhea-galactorrhea treated with bromocriptine.  Clin Exp Obstet Gynecol. 1995;  22 301-306
• 7 Steinberger E, Rodriguez-Rigau L J, Petak S M, Weidman E R, Smith K D, Ayala C. Glucocorticoid therapy in hyperandrogenism.  Baillieres Clin Obstet Gynaecol. 1990;  4 457-471
• 8 Daly D C, Walters C A, Soto-Albors C E, Tohan N, Riddick D H. A randomized study of dexamethasone in ovulation induction with clomiphene citrate.  Fertil Steril. 1984;  41 844-848
• 9 Hollmann M, Runnebaum B, Gerhard I. Effects of weight loss on the hormonal profile in obese, infertile women.  Hum Reprod. 1996;  11 1884-1891
• 10 Vandermolen D T, Ratts V S, Evans W S, Stovall D W, Kauma S W, Nestler J E. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone.  Fertil Steril. 2001;  75 310-315
• 11 Macklon N S, Fauser B C. Follicle development during the normal menstrual cycle.  Maturitas. 1998;  30 181-188
• 12 Nasseri S, Ledger W L. Clomiphene citrate in the twenty-first century.  Hum Fertil. 2001;  4 145-151
• 13 Balen A H, Braat D D, West C, Patel A, Jacobs H S. Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients.  Hum Reprod. 1994;  9 1563-1570
• 14 van Santbrink E J, Donderwinkel P F, van Dessel T J, Fauser B C. Gonadotrophin induction of ovulation using a step-down dose regimen: single-centre clinical experience in 82 patients.  Hum Reprod. 1995;  10 1048-1053
• 15 Brown J B. Pituitary control of ovarian function - concepts derived from gonadotrophin therapy.  Aust N Z J Obstet Gynaecol. 1978;  18 46-54
• 16 Gleicher N, Karande V. Forget about ovulation induction! Proceed directly to IVF. Ben-Raphael Z, Shoham Z, Frydman R Proceedings of the 2nd World Congress on Controversies in Obstetrics and Gynecology in Paris, France. Bologna; Monduzzi Editore 2001: 211-215
• 17 Homburg R, Insler V. Ovulation induction in perspective.  Hum Reprod Update. 2002;  8 449-462
• 18 Daya S. Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles. Cochrane Database Syst 2000 RevCD001299. 
• 19 Rickes D, Nickel I, Kropf S, Kleinstein J. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis.  Fertil Steril. 2002;  78 757-762
• 20 Damario M A, Barmat L, Liu H C, Davis O K, Rosenwaks Z. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.  Hum Reprod. 1997;  12 2359-2365
• 21 Barri P N, Martinez F, Coroleu B, Tur R. The role of GnRH antagonists in assisted reproduction.  Reprod Biomed Online. 2002;  5 14-19
• 22 Al Inany H, Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane review.  Hum Reprod. 2002;  17 874-885
• 23 Ludwig M, Katalinic A, Banz C, Diedrich K. Individual treatment using the GnRH antagonist Cetrotide(R): Optimization of treament.  Fertil Steril. 2002;  78 O51
• 24 Gordon K. New developments in gonadotrophin pharmacology.  Reprod Biomed Online. 2002;  5 259-264
• 25 Schoot D C, Harlin J, Shoham Z, Mannaerts B M, Lahlou N, Bouchard P, Bennink H J, Fauser B C. Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women.  Hum Reprod. 1994;  9 1237-1242
• 26 The European and Israeli Study Group on Highly Purified Menotropin versus Recombinant Follicle-Stimulating Hormone . Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial.  Fertil Steril. 2002;  78 520-528
• 27 Van Wely M, Westergaard L G, Van d V Bossuyt P M. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles. Cochrane Database Syst 2003; RevCD003973. 
• 28 Tesarik J, Mendoza C. Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence.  Hum Reprod. 2002;  17 3129-3137
• 29 Baer G, Loumaye E. Comparison of recombinant human luteinising hormone (r-hLH) and human menopausal gonadotropin (hMG) in assisted reproductive technology.  Curr Med Res Opin. 2003;  19 83-88
• 30 Lord J M, Flight I H, Norman R J. Metformin in polycystic ovary syndrome: systematic review and meta-analysis.  Brit Med J. 2003;  327 951-953
• 31 Mitwally M F, Casper R F. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate.  Fertil Steril. 2001;  75 305-309
• 32 Meduri G, Touraine P, Beau I, Lahuna O, Desroches A, Vacher-Lavenu M C, Kuttenn F, Misrahi M. Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological,.  and molecular studies J Clin Endocrinol Metab. 2003;  88 3491-3498
• 33 Grieshaber K, Greb R, Mempel A, Kiesel L, Behre H, Gromoll J, Nieschlag E, Simoni M. Subtle differences in the ovarian response after FSH stimulation due to FSH receptor polymorphism?.  Hum Reprod. 2003;  18 22-23